Protease Activity Assays

Substrate Selection by Enzyme Family

Substrate selectivity is determined by the active-site topology of each protease family. Using a substrate with poor sequence complementarity to the active site produces artificially low velocity estimates and unreliable inhibitor constants. The following recommendations reflect substrates that appear consistently in the primary literature for each family.

Matrix Metalloproteinases (MMPs) — MMP Activity Assay

MMPs are zinc-dependent endopeptidases with a preference for hydrophobic residues at P1′. The most widely used fluorogenic substrate class for the MMP activity assay is MCA-Pro-Leu-Gly~Leu-Dpa-Ala-Arg-NH₂ (where ~ denotes the scissile bond and Dpa is 3-(2,4-dinitrophenyl)-L-2,3-diaminopropionic acid), a FRET-quenched peptide based on the collagen α1(I) cleavage site. This substrate is cleaved by a broad range of MMPs including MMP-1, -2, -3, -7, -8, -9, -12, and -13, making it suitable for general MMP screening. Pan-MMP activity in conditioned medium is also commonly assessed by gelatin zymography, which differentiates pro-MMP-2 (72 kDa), active MMP-2 (62 kDa), pro-MMP-9 (92 kDa), and active MMP-9 (82 kDa) in a single gel lane.

For collagenase-specific activity (MMP-1, MMP-8, MMP-13), a collagenase activity assay using fluorescently labeled fibrillar collagen I (DQ-Collagen) or a FRET substrate incorporating the Gly~Ile scissile bond of the collagen α-chain provides better selectivity than generic MCA-peptides. All MMP assays require activation of the latent pro-form: activation with APMA (4-aminophenylmercuric acetate, 1 mM, 37 °C, 1 h) is standard for recombinant pro-MMPs.

Cathepsins — Cathepsin Activity Assay

The cathepsin family spans cysteine (B, C, H, K, L, S, V), aspartyl (D, E), and serine (A, G) proteases, and substrate selection must match the catalytic mechanism.

• Cathepsin B and L (cysteine): Z-Phe-Arg-AMC (Z-FR-AMC) is the canonical fluorogenic substrate, though cathepsin B also accepts Z-Arg-Arg-AMC (Z-RR-AMC), which cathepsin L does not, allowing discrimination. Assays are run at pH 5.5–6.0 in sodium acetate buffer with 2–5 mM DTT and 1–2 mM EDTA to maintain the active-site cysteine in reduced form.
• Cathepsin D (aspartyl): The FRET substrate MOCAc-Gly-Lys-Pro-Ile-Leu-Phe-Phe-Arg-Leu-Lys(Dnp)-D-Arg-NH₂ (MOCAc-GKPILFFRLK(Dnp)) is derived from the APP cleavage site and is highly selective for cathepsin D and related aspartyl proteases. Assays are run at pH 3.5–4.0 in sodium formate or acetate buffer. No reducing agent is required.
• Cathepsin K (cysteine): Z-Leu-Arg-AMC and the collagen-mimetic substrate Z-Gly-Pro-Arg-AMC are used in studies of bone-resorption models. Conditions mirror those for cathepsin B/L.
• Cathepsin S (cysteine): Z-Val-Val-Arg-AMC is selective for cathepsin S over cathepsin B at neutral to mildly acidic pH, which is relevant for studies of antigen presentation in immune cell models.

Calpains — Calpain Assay

Calpains (calpain-1, μ-calpain; calpain-2, m-calpain) are calcium-activated cysteine proteases. The standard calpain assay substrate is Suc-Leu-Leu-Val-Tyr-AMC (Suc-LLVY-AMC), run in HEPES or Tris buffer at pH 7.4 with 5–10 mM CaCl₂ to activate the enzyme. DTT (1–5 mM) is included to protect the active-site cysteine. The K_m for Suc-LLVY-AMC is typically in the 100–300 µM range for calpain-1; substrate concentrations of 50–200 µM are workable for kinetic measurements. Note that the 20S proteasome also cleaves Suc-LLVY-AMC; if cell lysates rather than purified recombinant protein are used, inclusion of a selective proteasome inhibitor (e.g., MG-132 at 10 µM) is necessary to isolate the calpain-specific signal.

Serine Proteases

Serine protease substrates exploit the preference of the S1 pocket: basic residues (Arg, Lys) for trypsin-like enzymes and hydrophobic residues (Phe, Ala) for chymotrypsin-like enzymes.

• Trypsin / trypsin-like (e.g., thrombin, plasmin, kallikreins): BApNA (chromogenic, Km ~1 mM for trypsin) or Tos-Gly-Pro-Arg-AMC (fluorogenic, for thrombin-like activity).
• Chymotrypsin / chymotrypsin-like (e.g., cathepsin G, elastase): Suc-Ala-Ala-Pro-Phe-AMC (AAPF-AMC) is the standard fluorogenic substrate; Suc-AAPF-pNA is the chromogenic equivalent. Both are run at pH 7.4–8.0.
• Elastase: MeO-Suc-Ala-Ala-Pro-Val-pNA or the AMC equivalent are standard for neutrophil elastase and pancreatic elastase assays.

BACE1 (β-Secretase)

BACE1 is an aspartyl protease that cleaves APP at the β-site. FRET substrates derived from the APP Swedish mutation sequence — e.g., Mca-Ser-Glu-Val-Asn-Leu-Asp-Ala-Glu-Phe-Arg-Lys(Dnp)-Arg-Arg-NH₂ — are the standard for BACE1 activity assays. Assays are conducted at pH 4.0–4.5 in sodium acetate buffer. BACE1 recombinant protein used for inhibitor screening is commonly the catalytic domain (residues ~46–460), produced in insect or mammalian cells to ensure correct disulfide bonding.

Buffer and Condition Optimization

Suboptimal assay conditions are the most frequent cause of irreproducible protease activity data. The critical variables are pH, reducing agents, divalent cations, and detergents.

Recommended assay buffer conditions by enzyme family

Enzyme Family	pH Range	Buffer	Reducing Agent	Key Cofactors / Notes
MMPs (collagenases, gelatinases)	7.2–7.5	50 mM HEPES or Tris-HCl	None (oxidizing environment)	5–10 mM CaCl₂; 0.05% Brij-35 to prevent nonspecific adsorption
Cathepsins B, L, K, S (cysteine)	5.5–6.5	50–100 mM sodium acetate	2–5 mM DTT or 5 mM cysteine	1–2 mM EDTA; pre-activate enzyme 10 min in buffer before adding substrate
Cathepsin D, BACE1 (aspartyl)	3.5–4.5	100 mM sodium acetate or formate	None	No cations required; avoid phosphate (inhibits aspartyl proteases)
Calpain-1, Calpain-2	7.0–7.5	25–50 mM HEPES	1–5 mM DTT	5–10 mM CaCl₂ required for activation; 1 mM EGTA controls for Ca²⁺ dependence
Serine proteases (trypsin-like)	7.5–8.5	50 mM Tris-HCl	None	100–150 mM NaCl stabilizes many serine proteases; avoid DTT (can reduce disulfides)
Serine proteases (chymotrypsin-like)	7.4–8.0	50 mM Tris-HCl or HEPES	None	0.1% BSA can stabilize dilute enzyme preparations

Two additional points warrant emphasis. First, fluorogenic substrates — particularly AMC conjugates — are prone to non-enzymatic hydrolysis at basic pH; always include a no-enzyme control at identical conditions and subtract this background. Second, organic solvents (DMSO, acetonitrile) used to dissolve hydrophobic substrates inhibit many proteases at concentrations above 1–2%; keep solvent concentration in the assay well below 1% where possible.

Using Recombinant Protein Standards for Calibration and Specific Activity

Quantitative protease activity data require a well-characterized recombinant enzyme standard. Specific activity — typically expressed as nmol substrate cleaved per minute per µg enzyme (nmol/min/µg), or as RFU/min/µg in fluorescent assays — normalizes for protein concentration and allows direct comparison across experiments, lots, and laboratories.

Establishing a Specific Activity Reference

To calculate specific activity, protein concentration must be measured by an accurate method (A280 with a sequence-derived extinction coefficient, or BCA against a matched protein standard — not Bradford, which responds unevenly to glycoproteins). The velocity used should be taken from the linear phase of the progress curve, at substrate concentrations below the K_m where first-order kinetics apply, or at a defined saturating concentration if V_max is being assessed. Include a positive control (recombinant enzyme of known activity) and a negative control (heat-inactivated enzyme or buffer blank) in every plate.

Triple Point Biologics assigns a specific activity value to every recombinant proteinase in the catalog, determined by in-house fluorogenic or chromogenic assay using the substrates described above. This value is printed on the certificate of analysis and provides an absolute benchmark for lot-to-lot comparison. All recombinant proteins are tested for activity prior to release; inactive or partially active lots are not released.

Lot-to-Lot Comparison and Long-Term Storage

Protease activity is sensitive to freeze-thaw cycling, oxidation of active-site cysteines, and autoproteolysis during storage. To minimize variability: aliquot single-use volumes upon receipt, store cysteine and aspartyl proteases with a reducing agent or stabilizing additive specified in the datasheet, and avoid repeated freeze-thaw. When switching lots, run the new and previous lot in parallel on the same day under identical conditions before committing to a large experiment.

Common Pitfalls and Troubleshooting

The following problems account for the majority of irreproducible or artifactual results in protease activity assays.

Auto-Activation and Contaminating Protease Activity

Many recombinant proteases are expressed and purified as zymogens (pro-forms) that require activation. Incomplete or inconsistent activation produces variable baseline activity. Conversely, over-activation — particularly with APMA for MMPs — can lead to autoproteolysis and loss of activity. Always confirm the activation state of the recombinant preparation by SDS-PAGE (reducing and non-reducing) before use. For preparations expressed in E. coli or insect cells, verify the absence of host-derived protease activity by running the expression host lysate (without the recombinant insert) at equivalent protein concentrations through the same assay.

Substrate Inhibition at High Concentrations

At substrate concentrations substantially above K_m, some proteases exhibit substrate inhibition — a decline in observed velocity at the highest substrate concentrations. If a full velocity-vs.-[S] curve deviates from Michaelis-Menten behavior at high [S], fit to a substrate inhibition model. Performing assays only at a single, arbitrarily chosen substrate concentration risks working in this inhibitory regime without knowing it.

Inner Filter Effect and Fluorescence Quenching

High concentrations of fluorogenic substrate — or of the liberated fluorophore product — can attenuate excitation or emission light (inner filter effect), producing a non-linear signal that underestimates velocity. This is particularly problematic with AMC substrates at concentrations above ~50–100 µM in standard microplate geometries. Conduct a substrate concentration optimization curve and verify that signal increases linearly with enzyme concentration at the chosen substrate concentration.

Cysteine Protease Oxidation

Cathepsins and calpains are exquisitely sensitive to active-site cysteine oxidation. If an unexpected loss of activity is observed, re-reduce the enzyme: incubate with 5–10 mM DTT for 15 min at room temperature in assay buffer, then dilute to working concentration and test immediately. If activity is not restored, the enzyme has likely undergone irreversible oxidative modification during storage.

DMSO Inhibition of Enzyme Activity

Inhibitor stocks are routinely prepared in DMSO. Many serine and aspartyl proteases show measurable inhibition at 2–5% DMSO; cysteine proteases are generally more tolerant. Standardize DMSO concentration across all wells including controls, and confirm that the chosen DMSO percentage does not affect uninhibited enzyme velocity by testing a DMSO-only dilution series.

Zymography vs. Solution-Phase Assays — Choosing the Right Format

Both formats measure protease activity, but they answer different questions. The choice is not merely a matter of convenience.

• Use zymography when: you need to detect gelatinolytic or caseinolytic activity in a biological sample (conditioned medium, tissue extract, serum) without prior purification; when molecular weight information is needed to distinguish pro- and active forms or multiple family members; or when you need to detect very low levels of MMP-2 or MMP-9 that fall below the sensitivity threshold of fluorogenic peptide assays.
• Use solution-phase fluorogenic assays when: you need quantitative kinetic parameters (K_m, V_max, k_cat); you are running inhibitor screens; you need high throughput; or you are working with purified recombinant protein and the question is specific activity or inhibitor IC50.
• Use HPLC/MS-based assays when: you need to map a cleavage site precisely, characterize activity against a physiologically relevant macromolecular substrate, or validate a novel substrate in the context of endogenous protein.

Zymography and fluorogenic solution assays are frequently run in parallel when characterizing a new inhibitor: zymography confirms selectivity for gelatinases in complex matrix, while solution-phase kinetics define the quantitative inhibition constant.

Triple Point Biologics Recombinant Proteins and Matched Antibodies

Since 1994, Triple Point Biologics has specialized in recombinant proteinases and their matched rabbit polyclonal antibodies. Every active enzyme in the catalog has a corresponding antibody produced by the same laboratory, against the same protein. This means the antibody used to confirm expression in a Western blot or localize the protease in tissue sections by IHC was validated against the same recombinant used in the activity assay — not against a different fragment from a different supplier.

The matched-pair design is particularly useful for:

• Correlating enzymatic activity data with expression-level data in the same sample set.
• Confirming that the recombinant protein used in an activity assay is the correct molecular weight and antigenically intact before committing it to kinetic experiments.
• Validating that an inhibitor identified in a biochemical IC50 assay reduces the endogenous protein's activity in cell lysates, using immunodepletion followed by activity measurement.

Browse the full recombinant protein catalog at /collections/recombinant-proteins and the matched antibody catalog at /collections/antibodies. Specific activity values, substrate and buffer conditions, and activation protocols are documented on each individual product page. For information on our quality and validation standards, see Quality and Validation. Custom expression or antibody generation against a protease not currently in the catalog can be discussed via Custom Services.

For a detailed background on the enzymology of individual protease families, see the related guides on MMP biology, lysosomal cathepsins, and calpain structure and function.